| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q38935002 | 4-hydroxy estrogen induces DNA damage on codon 130/131 of PTEN in endometrial carcinoma cells |
| Q47105042 | A case of pure-type ovarian squamous cell carcinoma producing granulocyte-colony stimulating factor |
| Q53306476 | A novel diagnostic biomarker for human uterine leiomyosarcoma: PSMB9/β1i |
| Q91937246 | Alcohol Consumption During Pregnancy and Risk of Placental Abnormality: The Japan Environment and Children's Study |
| Q91311048 | Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study |
| Q39929744 | Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E. |
| Q53817965 | BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression |
| Q84082530 | Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression |
| Q51073409 | Characterization of Leiomyomatoid Angiomatous Neuroendocrine Tumour (LANT)-like Tumour in the Myometrium with Histopathological Examination |
| Q38071813 | Clinical management of atypical polypoid adenomyoma of the uterus. A clinicopathological review of 29 cases |
| Q38348194 | Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A). |
| Q51018456 | Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA) |
| Q44306864 | Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium |
| Q37293935 | Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin |
| Q82577768 | Cystic clear cell tumor of borderline malignancy of the ovary lacking fibromatous components: report of two cases and a possible new histological subtype |
| Q85456854 | Diagnosis and treatment of endometrial stromal sarcoma |
| Q85457177 | Diagnosis and treatment of epithelioid trophoblastic tumor |
| Q51637566 | Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1. |
| Q36410067 | Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment |
| Q92363690 | Effectiveness of a genetic test panel designed for gynecological cancer: an exploratory study |
| Q45201662 | Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas |
| Q35718691 | Endometrial carcinoma in septate uterus detected 6 months after full-term delivery: case report and review of the literature |
| Q53344220 | Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells |
| Q38335730 | Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence |
| Q53647211 | Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma |
| Q41162447 | Expression of CAVEOLIN 1 in uterine mesenchymal tumors: No relationship between malignancy and CAVEOLIN 1 expression |
| Q81744382 | Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease |
| Q44644583 | Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki‐67 expression |
| Q42873406 | Fetal Goitrous Hypothyroidism due to Maternal Thyroid Stimulation-Blocking Antibody: A Case Report |
| Q40212310 | Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis |
| Q83353256 | Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF‐1α to a hypoxia‐induced, methylation‐free hypoxia response element of S100A4 gene |
| Q84565068 | Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma |
| Q39736131 | Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells |
| Q43162365 | Immunohistochemical detection of steroid receptor cofactors in ovarian endometriosis: involvement of down-regulated SRC-1 expression in the limited growth activity of the endometriotic epithelium |
| Q81451026 | Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression |
| Q86655191 | Immunohistochemical expression of core 2 β1,6-N-acetylglucosaminyl transferase 1 (C2GnT1) in endometrioid-type endometrial carcinoma: a novel potential prognostic factor |
| Q73493079 | Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator |
| Q51426849 | Immunohistochemical expression of keratan sulfate: a possible diagnostic marker for carcinomas of the female genital tract |
| Q80380532 | Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas |
| Q43282209 | Inverse correlation between Skp2 and p27(Kip1) in normal endometrium and endometrial carcinoma |
| Q48495617 | Involvement of pelvic inflammation–related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis |
| Q35731556 | Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcma. |
| Q36887594 | Laminin C1 expression by uterine carcinoma cells is associated with tumor progression |
| Q33824652 | Laser-captured microdissection-microarray analysis of the genes involved in endometrial carcinogenesis: stepwise up-regulation of lipocalin2 expression in normal and neoplastic endometria and its functional relevance |
| Q36139474 | Leiomyoma of the ovary presenting with Meigs' syndrome |
| Q98944516 | Limited frequency of malignant change in lobular endocervical glandular hyperplasia |
| Q36014604 | Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells |
| Q38806622 | Lipocalin 2 attenuates iron-related oxidative stress and prolongs the survival of ovarian clear cell carcinoma cells by up-regulating the CD44 variant. |
| Q91045298 | Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma |
| Q36922697 | Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma |
| Q34700785 | Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma |
| Q38995418 | Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma |
| Q48232904 | Mutation analysis by whole exome sequencing of endometrial hyperplasia and carcinoma in one patient: Abnormalities of polymerase epsilon and the phosphatidylinositol-3 kinase pathway. |
| Q78008409 | Nonimmune "Fulminant" type 1 diabetes presenting with diabetic ketoacidosis during pregnancy |
| Q44687211 | Nuclear localization of beta-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas. |
| Q56533517 | Oct4 Expression in Immature Teratoma of the Ovary |
| Q45247353 | Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection |
| Q80594142 | Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone-related hypercalcemia |
| Q87262832 | Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma |
| Q40164572 | Overexpression of hedgehog signaling molecules and its involvement in the proliferation of endometrial carcinoma cells |
| Q48128939 | Panobinostat Enhances Growth Suppressive Effects of Progestin on Endometrial Carcinoma by Increasing Progesterone Receptor and Mitogen-Inducible Gene-6. |
| Q38099701 | Placental Mesenchymal Dysplasia: Chronological Observation of Placental Images during Gestation and Review of the Literature |
| Q38205935 | Polypoid endometriosis of the ovary mimicking ovarian carcinoma dissemination: a case report and literature review |
| Q34016344 | Potential biomarker for human uterine leiomyosarcoma |
| Q84279456 | Potential role of LMP2 as an anti‐oncogenic factor in human uterine leiomyosarcoma: Morphological significance of calponin h1 |
| Q35619604 | Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy. |
| Q83541887 | Predicting the Route of Delivery in Women with Low-Lying Placenta Using Transvaginal Ultrasonography: Significance of Placental Migration and Marginal Sinus |
| Q81186256 | Prenatal diagnosis of amniotic sheets by magnetic resonance imaging |
| Q37391079 | Prenatal sonographic diagnosis of fetal valproate syndrome: a case report |
| Q37891639 | Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings |
| Q36169273 | Primary retroperitoneal mucinous cystadenoma of borderline malignancy: a case report and review of the literature |
| Q39393928 | Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells |
| Q40999646 | SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells. |
| Q35605268 | Sarcoma botryoides of the uterine cervix in a 46-year-old woman: case report and literature review |
| Q92152035 | Sawtooth fetal heart rate pattern associated with a favorable neurological outcome in an infant: a case report |
| Q38835509 | Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target. |
| Q92055364 | Trophoblast type-specific expression of senescence markers in the human placenta |
| Q91157196 | Two-sided role of estrogen on endometrial carcinogenesis: stimulator or suppressor? |
| Q39755948 | Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin |
| Q46026098 | Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma. |
| Q37412920 | Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation |
| Q104489530 | Usefulness of the 'cosmos pattern' for differentiating between cervical gastric-type mucin-positive lesions and other benign cervical cystic lesions in magnetic resonance images |
| Q83226250 | Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: a report of six cases |
| Q92889936 | Whole-exome sequencing of lobular endocervical glandular hyperplasia |
| Q94564896 | Worsening cytology and lesion enlargement are useful indicators for malignant transformation of lobular endocervical glandular hyperplasia during follow-up: A case report |
| Q85456869 | [Natural history and risk factors of ovarian cancer development] |
| Q80982733 | [Pathology of endometrial carcinoma] |
| Q90214633 | cDNA expression library screening revealed novel functional genes involved in clear cell carcinogenesis of the ovary in vitro |
| Q90045045 | αGlcNAc and its catalyst α4GnT are diagnostic and prognostic markers in uterine cervical tumor, gastric type |
Search more.